内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Conaway Dale H. Officer active across 1 company, notably Bioxytran, INC. Cumulatively, 13 filings have been published. History available since 2 April 2021. The latest transaction was disclosed on 12 August 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Conaway Dale H
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
10,417 股@ US$0.4850.9% 占其流量preferredSEC:0001445815-25-000009:0
97,535 股@ US$0.3156.5% 占其流量PreferredSEC:0001754429-25-000003:0
20,619 股@ US$0.461.9% 占其流量preferredSEC:0001754429-24-000010:0
123,967 股@ US$0.1213.0% 占其流量commonSEC:0001754429-24-000002:0
1,060,089 股@ US$0.16734.7% 占其流量commonSEC:0001754429-24-000002:1
212,018 股@ US$0.83534.7% 占其流量preferredSEC:0001754429-24-000002:2
70,423 股@ US$0.1422.0% 占其流量commonSEC:0001445815-24-000012:0
266,955 股@ US$0.1146.1% 占其流量commonSEC:0001445815-24-000008:0
77,721 股@ US$0.1933.1% 占其流量commonSEC:0001445815-23-000023:0
40,000 股@ US$0.151.2% 占其流量common stockSEC:0001445815-23-000017:0
30,000 股@ US$0.4482.7% 占其流量Common StockSEC:0001445815-23-000010:0
50,000 股@ US$0.232.4% 占其流量Common StockSEC:0001636357-22-000002:0
30,000 股@ US$0.170.9% 占其流量CommonSEC:0001539497-22-000079:0
About Conaway Dale H
CONAWAY DALE H is a Director of Bioxytran, INC (XNAS). He has 13 filings in total, and the 13 sampled filings cover the period from 2022-01-18 to 2025-11-18. The stated transaction nature is Attribution, and both buy and sell amounts are 0 EUR in the sampled recent filings.